Hone Health Raises $228M From Marcypen
Hone Health raises $228M Series A+ led by MarcyPen.
Hone Health, based in New York, has successfully raised $228M in a Series A+ funding round led by MarcyPen. This round consists of $28M in equity, while the remaining $200M comes from General Catalyst’s Customer Value Fund.
In addition to MarcyPen, Gwyneth Paltrow’s Kinship Ventures is among the investors supporting this funding round, which aims to enhance the platform's offerings in hormone and metabolic care.
Hone Health specializes in physician-led hormone and metabolic care, utilizing comprehensive diagnostic testing combined with physician expertise and AI-driven insights. The company has treated around 200,000 patients and generated over $100M in recurring revenue in the past year.
Founded by Saad Alam, Hone Health operates exclusively in the US and employs a team of approximately 450 staff, including physicians. Alam's personal experiences with health challenges prompted the creation of Hone, focusing on providing long-term engagement between patients and healthcare providers.
Alam emphasizes the importance of deep insights into personal health data, stating, “People have never had more data on their own bodies and never less guidance on what to do with it. Hone closes that gap by bringing serious diagnostics together with physicians who stay with you over the long term rather than just seeing you for a few appointments.”
| Company | Hone Health |
|---|---|
| Round | Series A+ |
| Amount | $228M |
| Lead Investor | MarcyPen |
| Founders | Saad Alam |
| Sectors | healthcare |
ABOUT THIS STORY
- Desk
- Articles
- Filed
- Nov 18, 2026
- By
- Traded Media